Researchers are harnessing an imaging technique called cryogenic electron microscopy to design drugs and better understand disease.
Tag: HIV
Enlisting the entire immune system strengthens potency of HIV vaccines in development
Two recent Stanford-led studies show the value of tweaking vaccines to enlist the entire immune system — not just part of it — in preventing HIV infection.
Marking World AIDS Day: A Q&A
Stanford Medicine researchers discuss prevention efforts and the importance of addressing the long-term health of people living with HIV.
Near-universal screening for HIV recommended in the U.S.
The U.S. Preventive Services Task Force now recommends HIV screening for those aged 15-65 and increased use of PrEP, a pill that helps prevent infection.
Patients at high risk of HIV should take daily preventative drug, a task force recommends
The U.S. Preventative Services Task Force encourages those who are at high risk of contracting HIV to take a daily pre-exposure drug.
Huge study shows cancer benefits, limitations of antiretroviral therapy for HIV
Antiretroviral therapy, a breakthrough treatment for HIV infection, suppresses the levels of circulating HIV viral particles in the blood. When it works, cancer rates drop, according to a new study. Still, even when the therapy is successful, HIV-positive individuals retain elevated rates of cancer.
A better way to test for HIV: Translate it into DNA
There are easy ways to test for HIV, and there are reliable ways, but easy and reliable? That's hard to come by — but perhaps not for long.
A small African country with a powerful voice
The recent film "A United Kingdom" tells the story of Botswana’s maverick first president who defied convention and caused an international scandal by marrying a …
Ebola infection may be asymptomatic, study finds
In the heat of the Ebola crisis in late 2014, Stanford’s Gene Richardson, MD, was among the brave physicians who volunteered in Sierra Leone to …
“A sense of panic”: Concern about funding dominates global AIDS summit
Stanford's Eran Bendavid, MD, is among the 18,000 people gathered this week in South Africa for the 21st International AIDS Conference. And he, like many others, …
Study shows that promoting abstinence, fidelity for HIV prevention is ineffective
PEPFAR, the U.S. government’s signature program for HIV treatment and prevention, has long supported projects in the developing world that encourage sexual abstinence and fidelity. …
Should we invest in HIV prevention for people who inject drugs?
People who inject drugs make up less than 1 percent of the U.S. adult population. But about 10 percent of new HIV infections in this …
Ultra-sensitive test for cancers & HIV developed by Stanford chemists
Stanford chemists have developed a highly sensitive and specific tool to screen for cancer and HIV — 1000 times more sensitive than current clinical tests. …
Drought causes spike in HIV infections in Africa
Here in California, the drought is plenty serious. Shortages mean short showers, brown lawns, empty reservoirs and fallow fields. But in sub-Saharan Africa, drought spreads …
Study: Chimps teach people a thing or two about HIV resistance
I, personally, have never had trouble distinguishing a human being from a chimp. I look, and I know. But I'm not a molecular biologist. Today's …
Spread of drug-resistant HIV in Africa and Asia is limited, Stanford research finds
In the last decade, millions more people in the developing world have gained access to anti-viral drugs to treat HIV, with nearly 12 million now …